{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:36:54Z","timestamp":1790624214093,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ejpb.2022.11.012","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T02:34:08Z","timestamp":1668479648000},"page":"195-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Predicting in vitro lung deposition behavior of combined dry powder inhaler via rheological properties"],"prefix":"10.1016","volume":"181","author":[{"given":"Jiayi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxiao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoli","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2022.11.012_b0005","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2147\/COPD.S252435","article-title":"Nebulized Therapies in COPD: Past Present, and the Future","volume":"15","author":"Barjaktarevic","year":"2020","journal-title":"Int. J. Chronic Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.ejpb.2022.11.012_b0010","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4155\/tde-2017-0037","article-title":"Drug delivery to the lungs: challenges and opportunities","volume":"8","author":"Newman","year":"2017","journal-title":"Therapeutic delivery"},{"key":"10.1016\/j.ejpb.2022.11.012_b0015","first-page":"471","article-title":"The effect of ethanol on the habit and in vitro aerodynamic results of dry powder inhalation formulations containing ciprofloxacin hydrochloride","volume":"16","author":"Benke","year":"2021","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2022.11.012_b0020","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.apsb.2016.03.011","article-title":"Influence of physical properties of carrier on the performance of dry powder inhalers","volume":"6","author":"Peng","year":"2016","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.ejpb.2022.11.012_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.04.002","article-title":"Does carrier size matter? A fundamental study of drug aerosolisation from carrier based dry powder inhalation systems","volume":"413","author":"Ooi","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.11.012_b0030","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijpharm.2017.12.004","article-title":"Performance indicators for carrier-based DPIs: Carrier surface properties for capsule filling and API properties for in vitro aerosolisation","volume":"536","author":"Faulhammer","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.11.012_b0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.addr.2011.04.004","article-title":"A critical view on lactose-based drug formulation and device studies for dry powder inhalation: Which are relevant and what interactions to expect?","volume":"64","author":"de Boer","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2022.11.012_b0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijpharm.2010.04.032","article-title":"Improving aerosolization of drug powders by reducing powder intrinsic cohesion via a mechanical dry coating approach","volume":"394","author":"Zhou","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.11.012_b0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2004.02.002","article-title":"The influence of carrier roughness on adhesion, content uniformity and the in vitro deposition of terbutaline sulphate from dry powder inhalers","volume":"275","author":"Flament","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.11.012_b0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijpharm.2010.02.011","article-title":"Surface modification of lactose inhalation blends by moisture","volume":"391","author":"Watling","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.11.012_b0055","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijpharm.2016.01.076","article-title":"A review of factors affecting electrostatic charging of pharmaceuticals and adhesive mixtures for inhalation","volume":"503","author":"Kaialy","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.11.012_b0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.powtec.2012.04.062","article-title":"Arising of electrostatic charge in the mixing process and its influencing factors","volume":"226","author":"Karner","year":"2012","journal-title":"Powder Technol."},{"key":"10.1016\/j.ejpb.2022.11.012_b0065","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijpharm.2015.06.044","article-title":"Carrier-based dry powder inhalation: Impact of carrier modification on capsule filling processability and in vitro aerodynamic performance","volume":"491","author":"Faulhammer","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.11.012_b0070","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.powtec.2018.08.058","article-title":"Effect of powder properties on the aerosolization performance of nanoporous mannitol particles as dry powder inhalation carriers","volume":"358","author":"Zhang","year":"2019","journal-title":"Powder Technol."},{"key":"10.1016\/j.ejpb.2022.11.012_b0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijpharm.2017.10.052","article-title":"Powder flow analysis: A simple method to indicate the ideal amount of lactose fines in dry powder inhaler formulations","volume":"535","author":"Hertel","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.11.012_b0080","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijpharm.2010.01.028","article-title":"Characterisation and functionality of inhalation anhydrous lactose","volume":"390","author":"Pitchayajittipong","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.11.012_b0085","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ejpb.2010.09.003","article-title":"Air permeability of powder: A potential tool for Dry Powder Inhaler formulation development","volume":"76","author":"Le","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2022.11.012_b0090","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijpharm.2014.08.038","article-title":"An insight into powder entrainment and drug delivery mechanisms from a modified Rotahaler (R)","volume":"477","author":"Sim","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.11.012_b0095","doi-asserted-by":"crossref","first-page":"119000","DOI":"10.1016\/j.ijpharm.2019.119000","article-title":"Exploring the influence of drug content on DPI powder properties and potential prediction of pulmonary drug deposition","volume":"575","author":"Sun","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.11.012_b0100","doi-asserted-by":"crossref","first-page":"119798","DOI":"10.1016\/j.ijpharm.2020.119798","article-title":"Exploring the potential influence of drug charge on downstream deposition behaviour of DPI powders","volume":"588","author":"Sun","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.11.012_b0105","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-021-00582-0","article-title":"Elucidating the Effect of Fine Lactose Ratio on the Rheological Properties and Aerodynamic Behavior of Dry Powder for Inhalation","volume":"23","author":"Sun","year":"2021","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2022.11.012_b0110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jconrel.2018.05.031","article-title":"Sustained therapeutic efficacy of budesonide-loaded chitosan swellable microparticles after lung delivery: Influence of in vitro release, treatment interval and dose","volume":"283","author":"Zhang","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2022.11.012_b0115","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11095-007-9467-1","article-title":"An investigation into the dispersion mechanisms of ternary dry powder inhaler formulations by the quantification of interparticulate forces","volume":"25","author":"Jones","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2022.11.012_b0120","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1007\/s11095-011-0640-1","article-title":"Investigation into the Influence of Primary Crystallization Conditions on the Mechanical Properties and Secondary Processing Behaviour of Fluticasone Propionate for Carrier Based Dry Powder Inhaler Formulations","volume":"29","author":"Kubavat","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2022.11.012_b0125","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijpharm.2017.08.113","article-title":"Particle interactions of fluticasone propionate and salmeterol xinafoate detected with single particle aerosol mass spectrometry (SPAMS)","volume":"532","author":"Jetzer","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.11.012_b0130","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s11095-008-9538-y","article-title":"The role of fines in the modification of the fluidization and dispersion mechanism within dry powder inhaler formulations","volume":"25","author":"Shur","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2022.11.012_b0135","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/17425247.2018.1450865","article-title":"Low density, good flowability cyclodextrin-raffinose binary carrier for dry powder inhaler: anti-hygroscopicity and aerosolization performance enhancement","volume":"15","author":"Zhao","year":"2018","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/j.ejpb.2022.11.012_b0140","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1208\/s12249-017-0898-7","article-title":"The Relationship Between the Permeability and the Performance of Carrier-Based Dry Powder Inhalation Mixtures: New Insights and Practical Guidance","volume":"19","author":"Shalash","year":"2018","journal-title":"Aaps Pharmscitech"},{"key":"10.1016\/j.ejpb.2022.11.012_b0145","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ejpb.2012.07.018","article-title":"Capabilities and limitations of using powder rheology and permeability to predict dry powder inhaler performance","volume":"82","author":"Cordts","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2022.11.012_b0150","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1023\/A:1020464801786","article-title":"Particle interactions involved in aerosol dispersion of ternary interactive mixtures","volume":"19","author":"Louey","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2022.11.012_b0155","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ejps.2010.04.012","article-title":"Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders","volume":"40","author":"Zhou","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2022.11.012_b0160","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejpb.2022.08.007","article-title":"Elucidation of lactose fine size and drug shape on rheological properties and aerodynamic behavior of dry powders for inhalation","volume":"179","author":"Sun","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2022.11.012_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121407","article-title":"Insights into the potential of rheological measurements in development of dry powder inhalation formulations","volume":"614","author":"Almansour","year":"2022","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641122002715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641122002715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:50:53Z","timestamp":1760547053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641122002715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":33,"alternative-id":["S0939641122002715"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.11.012","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting in vitro lung deposition behavior of combined dry powder inhaler via rheological properties","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}